Topical delivery of selected growth factors
| dc.contributor.author | Van Niekerk, L. | |
| dc.contributor.author | Campell, B. | |
| dc.contributor.author | Gerber, M. | |
| dc.contributor.author | Du Plessis, L.H. | |
| dc.contributor.author | Du Plessis, J. | |
| dc.contributor.researchID | 12014451 - Van Niekerk, Lizl-Louise | |
| dc.contributor.researchID | 11329025 - Gerber, Minja | |
| dc.contributor.researchID | 11948388 - Du Plessis, Lissinda Hester | |
| dc.contributor.researchID | 10065318 - Du Plessis, Jeanetta | |
| dc.date.accessioned | 2018-04-30T13:15:54Z | |
| dc.date.available | 2018-04-30T13:15:54Z | |
| dc.date.issued | 2010 | |
| dc.description.abstract | Growth factors can benefit from controlled release admin- istration technologies (i.e. topical or transdermal delivery). When compared with other epithelial membranes, the skin has less enzymatic activity and so provides a more stable dosage medium and prolongs the delivery. The growth factors that were considered during this study are used for the treatment of alopecia (IGF-1, VEGF and KGF) and pigmentation (TNF-a & TGF-b) | en_US |
| dc.identifier.citation | Van Niekerk, L. et al. 2010. Topical delivery of selected growth factors. (In Perspectives in percutaneous penetration, 12th International Conference, 7-10 April, 2010, La Grande Motte, France). Journal of pharmacy and pharmacology, 62(6):789. [https://doi.org/10.1211/jpp.62.06.0016] | en_US |
| dc.identifier.issn | 0022-3573 | |
| dc.identifier.uri | http://hdl.handle.net/10394/26827 | |
| dc.identifier.uri | https://onlinelibrary.wiley.com/doi/epdf/10.1211/jpp.62.06.0016 | |
| dc.identifier.uri | https://doi.org/10.1211/jpp.62.06.0016 | |
| dc.identifier.uri | https://www.researchgate.net/publication/265612459_Topical_delivery_of_selected_growth_factors | |
| dc.language.iso | en | en_US |
| dc.publisher | Wiley | |
| dc.title | Topical delivery of selected growth factors | en_US |
| dc.type | Presentation | en_US |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.61 KB
- Format:
- Item-specific license agreed upon to submission
- Description: